Announcements Trials

Browse Landscape

Sponsor

Conditions

Tuberous Sclerosis 3 Seizures 3 Sturge-Weber Syndrome 2 Tuberous Sclerosis 2 1 Tuberous Sclerosis 1 1 Spasms, Infantile 1 Lennox Gastaut Syndrome 1 Glioblastoma 1 Epilepsy 1 Epilepsies, Myoclonic 1 Drug Resistant Epilepsy 1 Cognitive Dysfunction 1 Chemotherapy-Induced Peripheral Neuropathy 1 Breast Neoplasms 1 Arthralgia 1 Anxiety Disorders 1

Interventions

Sorafenib 23 Bevacizumab 11 Radiosurgery 6 Capecitabine 6 Radiofrequency Ablation 5 Oxaliplatin 5 Fluorouracil 5 Doxorubicin 5 pembrolizumab 4 Sunitinib 4 Erlotinib Hydrochloride 4 Cisplatin 4 Ramucirumab 3 Radiotherapy 3 Nivolumab 3 Leucovorin 3 Carboplatin 3 tremelimumab 2 spartalizumab 2 perflutren 2 derazantinib 2 carotuximab 2 Mitomycin 2 Magnetic Resonance Spectroscopy 2 Magnetic Resonance Imaging 2 Ipilimumab 2 Immunohistochemistry 2 Gemcitabine 2 Folfox protocol 2 Fluorodeoxyglucose F18 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Liver Neoplasms × Cannabidiol × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡